Bhumirajanagarindra Kidney Institute, Thailand Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2016
NCT04122222
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bhumirajanagarindra Kidney Institute, Thailand

Active Ingredients

Drugs in Phase 4 Trials (1)

inactivated influenza vaccine (2 trials)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 1